160 related articles for article (PubMed ID: 37903321)
21. [Significance of soluble CD163 and soluble CD25 in diagnosis and treatment of children with hemophagocytic lymphohistiocytosis].
Wang Y; Liu D; Zhu G; Yin C; Sheng G; Zhao X
Zhonghua Er Ke Za Zhi; 2015 Nov; 53(11):824-9. PubMed ID: 26758320
[TBL] [Abstract][Full Text] [Related]
22. Hemophagocytic Lymphohistiocytosis Associated With Parvovirus B19 in a Patient With Acquired Immunodeficiency Syndrome.
Macauley P; Abu-Hishmeh M; Dumancas C; Alexander-Rajan V; Piedra-Chavez F; Nada K; Habtes I; Popescu A; Mamorska-Dyga A
J Investig Med High Impact Case Rep; 2019; 7():2324709619883698. PubMed ID: 31635495
[TBL] [Abstract][Full Text] [Related]
23. Secondary hemophagocytic lymphohistiocytosis in pediatric patients: a single center experience and factors that influenced patient prognosis.
Oguz MM; Sahin G; Altinel Acoglu E; Polat E; Yucel H; Oztek Celebi FZ; Unsal H; Akcaboy M; Sari E; Senel S
Pediatr Hematol Oncol; 2019 Feb; 36(1):1-16. PubMed ID: 30821552
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of Moderately Dosed Etoposide in Macrophage Activation Syndrome-Hemophagocytic Lymphohistiocytosis.
Horne A; von Bahr Greenwood T; Chiang SCC; Meeths M; Björklund C; Ekelund M; Erensjö P; Berg S; Hagelberg S; Bryceson YT; Andersson U; Henter JI
J Rheumatol; 2021 Oct; 48(10):1596-1602. PubMed ID: 33589555
[TBL] [Abstract][Full Text] [Related]
25. Pediatric hemophagocytic lymphohistiocytosis in a tropical country: Results of a multicenter study in Thailand.
Rungrojjananon N; Pakakasama S; Winaichatsak A; Siriwanawong R; Rujkijyanont P; Traivaree C; Photia A; Monsereenusorn C
Asia Pac J Clin Oncol; 2023 Apr; 19(2):e128-e137. PubMed ID: 35712989
[TBL] [Abstract][Full Text] [Related]
26. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
Demirkol D; Yildizdas D; Bayrakci B; Karapinar B; Kendirli T; Koroglu TF; Dursun O; Erkek N; Gedik H; Citak A; Kesici S; Karabocuoglu M; Carcillo JA;
Crit Care; 2012 Dec; 16(2):R52. PubMed ID: 22715953
[TBL] [Abstract][Full Text] [Related]
27. Hemophagocytic Lymphohistiocytosis in Renal Transplant Recipients: A 2-Case Report.
Mascia G; Argiolas D; Carta E; Ibba S; Piredda GB
Transplant Proc; 2020 Jun; 52(5):1566-1569. PubMed ID: 32389490
[TBL] [Abstract][Full Text] [Related]
28. Characteristics and predictors of post-transplant-associated hemophagocytic lymphohistiocytosis in adults.
Hattori N; Sato M; Uesugi Y; Nakata A; Sasaki Y; Shimada S; Watanuki M; Fujiwara S; Kawaguchi Y; Arai N; Uto Y; Matsui T; Yanagisawa K; Tahara S; Koeffler HP; Iezumi K; Nakamaki T
Int J Hematol; 2021 May; 113(5):693-702. PubMed ID: 33385294
[TBL] [Abstract][Full Text] [Related]
29. Up-regulated serum levels of soluble CD25 and soluble CD163 in pediatric patients with SARS-CoV-2.
Mostafa GA; Ibrahim HM; Al Sayed Shehab A; Gendy YGE; Aly DMM; Shousha GAH
Eur J Pediatr; 2022 Jun; 181(6):2299-2309. PubMed ID: 35233677
[TBL] [Abstract][Full Text] [Related]
30. Using etoposide + dexamethasone-based regimens to treat nasal type extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
Wei L; Yang L; Cong J; Ye J; Li X; Yao N; Yang J; Ding J; Wang J
J Cancer Res Clin Oncol; 2021 Mar; 147(3):863-869. PubMed ID: 33025280
[TBL] [Abstract][Full Text] [Related]
31. IFN-α induced systemic lupus erythematosus complicated with hemophagocytic lymphohistiocytosis: a case report and literature review.
Zeng Z; Tu W; Ji B; Liu J; Huang K; Nie D; Yang L
Front Immunol; 2023; 14():1223062. PubMed ID: 37600795
[TBL] [Abstract][Full Text] [Related]
32. A Review of Current and Emerging Therapeutic Options for Hemophagocytic Lymphohistiocytosis.
Summerlin J; Wells DA; Anderson MK; Halford Z
Ann Pharmacother; 2023 Jul; 57(7):867-879. PubMed ID: 36349896
[TBL] [Abstract][Full Text] [Related]
33. Lamotrigine-associated hemophagocytic lymphohistiocytosis.
Suleman N; Ozdemirli M; Weisman D
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33408106
[TBL] [Abstract][Full Text] [Related]
34. Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: A systematic scoping review.
Hayden A; Park S; Giustini D; Lee AY; Chen LY
Blood Rev; 2016 Nov; 30(6):411-420. PubMed ID: 27238576
[TBL] [Abstract][Full Text] [Related]
35. The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis.
Bami S; Vagrecha A; Soberman D; Badawi M; Cannone D; Lipton JM; Cron RQ; Levy CF
Pediatr Blood Cancer; 2020 Nov; 67(11):e28581. PubMed ID: 32725881
[TBL] [Abstract][Full Text] [Related]
36. Diagnosing and treating hemophagocytic lymphohistiocytosis in the tropics: systematic review from the Indian subcontinent.
Rajagopala S; Singh N
Acta Med Acad; 2012; 41(2):161-74. PubMed ID: 23331391
[TBL] [Abstract][Full Text] [Related]
37. Hemophagocytic histiocytosis in severe SARS-CoV-2 infection: A bone marrow study.
Dandu H; Yadav G; Malhotra HS; Pandey S; Sachu R; Dubey K
Int J Lab Hematol; 2021 Dec; 43(6):1291-1301. PubMed ID: 34086418
[TBL] [Abstract][Full Text] [Related]
38. Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis.
Keenan C; Nichols KE; Albeituni S
Front Immunol; 2021; 12():614704. PubMed ID: 33664745
[TBL] [Abstract][Full Text] [Related]
39. The Efficacy of Etoposide-Based Therapy in Adult Secondary Hemophagocytic Lymphohistiocytosis.
Naymagon L; Tremblay D; Mascarenhas J
Acta Haematol; 2021; 144(5):560-568. PubMed ID: 33827086
[TBL] [Abstract][Full Text] [Related]
40. [Ruxolitinib combined with liposomal doxorubicin, etoposide, methylprednisolone+/-PEG-asparaginase in treatment of relapsed/refractory pediatric hemophagocytic lymphohistiocytosis].
Wei A; Ma HH; Zhang LP; Lian HY; Du JY; Wang D; Cui L; Ou WX; Zhao YZ; Zhao XX; Zhang L; Li ZG; Wang TY; Zhang R
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2167-2172. PubMed ID: 35872580
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
